Clinical Trial Update: Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the immune response to influenza vaccination in patients with MELAS syndrome; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melas Syndrome

Drugs mentioned

• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: Stanford University | Conditions: MELAS Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2017-04-21